Neuland Laboratories Ltd. is a global provider of active pharmaceutical ingredients (APIs) contract development and manufacturing organization (CDMO) services. It is focused on manufacture and sale of active pharmaceutical ingredients and allied services. It supports biotechnology and pharmaceutical companies in the design, development and manufacturing of complex APIs. It has two business verticals: generic drug substances (GDS) and custom manufacturing solutions (CMS). It develops and manufactures non-exclusive APIs both Prime APIs comprising large volume, mature molecules, and specialty APIs comprising lower volume, complex molecules with less competition. It develops small molecules and peptides for clinical trials and beyond. It provides an end-to-end continuum of customized services from early-stage drug development (Pre-IND) through to commercial manufacturing of complex APIs, including process development, process optimization, analytical testing, and regulatory support.As of 25 May 2026, Neuland Lab share price is ₹16,758.00. The stock opened at ₹16,785.00, compared to its previous close of ₹16,693.00. During today's trading session, Neuland Lab share price moved in the range of ₹16,650.00 to ₹17,000.00, with an average price of ₹16,825.00 for the day. Looking at its last 52-week, the stock has touched a low of ₹16,650.00 and a high of ₹17,000.00. On the performance front, Neuland Lab share price has increased by 0.57% over the last six months and is up 49.14% on a year-on-year basis.
The market capitalization of Neuland Lab is ₹21,341 Crs, with a P/E ratio of 58.6 and a dividend yield of 0.21%.